InvestorsHub Logo

PINKribbon

09/13/17 4:23 PM

#74980 RE: Triple9 #74979

I wildly agree with you Trip. And what I think I see playing out with a possible partnership, or buyout, is PharmaCyte preparing (just in case) for an uplist.

I've read where a reverse split normally coincides with an offering to a third-party.

4+ million dollars and no debt makes for a decent balance sheet, along with a reverse split to get the capital structure in line, all makes sense.

Make things right for the suiter. :) :) :)

Go PharmaCyte!!!

tjclark0551

09/13/17 4:35 PM

#74983 RE: Triple9 #74979

I feel the same way too. I just posted that because, so quickly a few on here try to paint a negative picture. They continually talk dilution and R/S. There is a strategic plan in place all one needs to do is connect the dots and the picture becomes clearer. Certainly it would be nice to hear some confirming news that supports our assumptions and take the edge off of whatever doubts one is experiencing. So, KW if you happen to be checking in on this board send us some sunshine.

pennyvestor

09/13/17 9:21 PM

#75000 RE: Triple9 #74979

'Triple9', well thought out post. Great things are going to happen here soon.

rudygerner

09/14/17 7:51 AM

#75010 RE: Triple9 #74979

I really like careful, deliberate and strategic.

I look forward to the morning when us longs are greeted by a massive gap up followed by the IND announcement. Then another gap up followed by first patient enrollment. And then a seismic gap up with a buyout/partnership announcement. It's coming.

Good to have you on board, Trip.

See you in Vegas.